Get notified when TWST files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Dilution Per Share to New Investors Participating In This Offering $86.35 (new) — New investors pay $96.00 per share for a company with net tangible book value of only $5.60 per share, resulting in immediate dilution of $86.35 per share.
Twist Bioscience prices 3.125M-share offering at $96.00, raising $300M gross for the company
Filed August 5, 2026 · ~1 min read
Key Changes
-
high
After underwriting discounts and expenses, the company expects net proceeds of approximately $284.3M.
Use of Proceeds verify on EDGAR → -
medium
The company plans to use net proceeds for R&D, manufacturing expansion, product offerings, and general corporate purposes.
Use of Proceeds verify on EDGAR → -
high
New investors face immediate dilution of $86.35 per share, as the offering price far exceeds the net tangible book value of $5.60 per share.
Dilution verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (HAIN 10-K) is open in full — no account needed.
Partner
Trade TWST commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Aug 31, 2026 · How we verify